Evidence map›Paper›PMID 34339276›Full record

ArticleAntimicrobial agents and chemotherapy2021

Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring

Catharine Prussing, Theresa Canulla, Navjot Singh, Patricia McAuley, Michael Gosciminski, Ewa King, Utpala Bandy, María-José Machado, Maria Karlsson, Kimberlee A Musser and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Catharine PrussingWadsworth Center, New York State Department of Health, Albany, New York, USA.ORCID 0000-0001-6425-6839
Theresa CanullaCenter for Biological Sciences, Providence, Rhode Island, USA.
Navjot SinghWadsworth Center, New York State Department of Health, Albany, New York, USA.
Patricia McAuleyRhode Island Department of Healthgrid.280336.c, Providence, Rhode Island, USA.
Michael GosciminskiRhode Island Department of Healthgrid.280336.c, Providence, Rhode Island, USA.
Ewa KingRhode Island State Health Laboratory, Providence, Rhode Island, USA.
Utpala BandyRhode Island Department of Healthgrid.280336.c, Providence, Rhode Island, USA.
María-José MachadoDivision of Healthcare Quality Promotion, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Maria KarlssonDivision of Healthcare Quality Promotion, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.ORCID 0000-0002-2463-0598
Kimberlee A MusserWadsworth Center, New York State Department of Health, Albany, New York, USA.ORCID 0000-0003-1922-5405
Richard C HuardCenter for Biological Sciences, Providence, Rhode Island, USA.
Elizabeth J NazarianWadsworth Center, New York State Department of Health, Albany, New York, USA.

Funding

NCEZID CDC HHS U50 CK000423OSELS CDC HHS U60 OE000103
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsHumansMicrobial Sensitivity TestsUnited StatesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsantibiotic resistancebeta-lactamasescarbapenemsgenome analysislong-read sequencingPseudomonas aeruginosa

Identifiers

PMID34339276
PMCPMC8448160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.